Saturday, October 3, 2026

USD/EUR Went Down By Over 3% In The Last 21 Sessions

ViaNews Editorial Team

November 30, 2023

USD/EUR Went Down By Over 3% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 3.24% for the last 21 sessions. At 17:06 EST on Thursday, 30 November, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 3.135% up from its 52-week low and 4.887% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.26%, a negative 0.20%, and a positive 0.32%, respectively.

USD/EUR's highest amplitude of average volatility was 0.26% (last week), 0.37% (last month), and 0.32% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • According to FXStreet on Tuesday, 28 November, "A return to 0.9713 (200-DMA) still appears ambitious with a push in EUR/USD above 1.10."
  • Eur/usd cracks 1.1000 as US dollar recedes across the board. According to FXStreet on Tuesday, 28 November, "The Euro's rally fueled by Greenback-selling across the broader FX marketspace sees the EUR/USD clipping into the 1.1000 handle, climbing four-tenths of a percent with further gains on the cards if market sentiment continues to climb.", "The EUR/USD has ticked into a fresh 15-week high above the 1.1000 major handle on Tuesday, fueled by a broad-market US Dollar (USD) selloff that is sending the Euro (EUR) higher as investor risk appetite climbs heading into the mid-week."
  • Eur/usd refreshes multi-month peak as fed rate cut bets continue to undermine the USD. According to FXStreet on Tuesday, 28 November, "This will be followed by the flash Eurozone CPI report on Thursday and the US Core PCE Price Index - the Fed's preferred inflation gauge - on Thursday, which, in turn, will drive the EUR/USD pair in the near term.", "This, in turn, validates the positive outlook for the EUR/USD pair and supports prospects for a further appreciating move."
  • Eur/usd price analysis: the key contention level is seen at the 1.0890–1.0900 zone. According to FXStreet on Tuesday, 28 November, "The EUR/USD pair snaps the three-day winning streak during the early European session on Tuesday. ", " Technically, the EUR/USD pair maintains a bullish outlook as the major pair holds above the 50- and 100-hour Exponential Moving Averages (EMA) on the four-hour chart. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com